AG真人官方

Form 4 filing for Alignment Healthcare (ALHC) shows Director Joseph S. Konowiecki sold 25,000 common shares on 31 Jul 2025 at $16.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted 5 Mar 2025. Gross proceeds equal roughly $400k.

Following the sale, Konowiecki鈥檚 direct ownership stands at 1,152,049 shares. No derivative securities were reported. The transaction does not alter board status and no other insider activity is disclosed in this filing.

Alignment Healthcare, Inc. (ALHC) 鈥� Form 144 filing

An insider intends to sell up to 25,000 common shares (鈮�0.013% of the 198,031,417 shares outstanding) through broker Justin Tabit on or about 31 Jul 2025. The shares, valued at an estimated $398,750, were originally received on 6 Oct 2014 as equity awards from Joseph Konowiecki. No related sales have been made in the past three months. The filer confirms possession of no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.

Alignment Healthcare (ALHC) Q2-25 10-Q highlights

Revenue climbed 49% year-over-year to $1.015 bn, driven by earned premiums of $1.006 bn. Medical expenses grew 46% to $881.7 m, but the medical loss ratio improvement helped swing operating results to a $22.7 m profit versus a $18.4 m loss in Q2-24. Net income attributable to shareholders reached $15.7 m, or $0.07 diluted EPS, reversing the prior-year $(0.13) loss.

For the first six months, revenue rose 48% to $1.94 bn with net income of $6.6 m. Cash and equivalents increased to $470.3 m, supporting total assets of $1.0 bn. Long-term debt stayed at $322.3 m after the Nov-24 issuance of 4.25% convertible notes; quarterly interest expense fell to $4.0 m. Stockholders鈥� equity improved to $141.0 m as the accumulated deficit narrowed.

Key ratios

• Operating margin: 2.2% vs (2.7)% YoY
• Medical expenses/Revenue: 86.9% vs 88.8%
• Cash & short-term investments: $505.8 m

Management noted an immaterial exit from the ACO REACH model effective 31-Dec-25 and confirmed compliance with all RBC/TNE capital rules. No new financial guidance was issued.

On 30 July 2025, Spok Holdings, Inc. (NASDAQ: SPOK) filed a Form 8-K reporting two routine but relevant items.

• Item 2.02 鈥� Earnings release: The company furnished a press release (Exhibit 99.1) announcing financial results for the quarter ended 30 June 2025. The filing itself does not include quantitative figures; investors must refer to the attached release for specifics.
• Item 8.01 鈥� Dividend declaration: The Board approved a regular quarterly cash dividend of $0.3125 per share, payable 9 September 2025 to shareholders of record on 19 August 2025, reinforcing the firm鈥檚 ongoing capital-return program.

No other material events, financial statements, or strategic actions were disclosed.

The Vanguard Group filed Amendment No. 3 to its Schedule 13G disclosing a passive 8.4 % stake (13,564,336 shares) in Coursera Inc (CUSIP 22266M104) as of 30 Jun 2025. Vanguard reports no sole voting rights; it shares voting power over only 163,828 shares, reflecting its index-tracking, non-activist posture. Conversely, it holds sole dispositive power over 13.25 million shares and shared dispositive power over 315,517 shares, allowing it to trade the bulk of the position while refraining from governance influence.

The filing is made under Rule 13d-1(b) as Vanguard qualifies as an investment adviser ("IA"). Vanguard certifies the shares were acquired in the ordinary course of business and not to influence control of Coursera. The ownership level crosses the 5 % threshold, requiring disclosure but does not signal any change-of-control intent or activist campaign.

XCF Global, Inc. (NASDAQ: SAFX) filed an 8-K disclosing two related amendments executed on July 10 2025:

• Amendment No. 1 to a Promissory Note (originally dated May 30 2025) among Focus Impact BH3 NewCo, Inc. (borrower), Helena Global Investment Opportunities I Ltd ("Helena") and Randall Soule. In exchange for a $2,249,771.14 cash payment from Helena, the Company and Soule waived Helena鈥檚 obligation to return certain Class A common shares that had been subject to Section 11.2 of the original note.
• Soule Amendment to Share Issuance Agreement (dated May 30 2025) under which Soule will return unspecified Class A shares to the Company for cancellation.

Because Amendment No. 1 alters the payment terms, the disclosure is also reported under Item 2.03 (creation of a direct financial obligation). Forms of both amendments are attached as Exhibits 10.1 and 10.2.

Key take-aways for investors:

• The Company receives $2.25 million in cash, enhancing near-term liquidity.
• The waiver means Helena retains shares that would otherwise have been returned, potentially maintaining share count higher than previously expected.
• Soule鈥檚 return of shares partly offsets the dilution, but the precise number of shares affected is not disclosed in the filing.

UiPath, Inc. (PATH) 鈥� Form 4 insider transaction

• On 11 July 2025, co-founder, CEO, Chairman and 10% owner Daniel Dines reported the sale of 45,000 Class A shares at a VWAP of $12.7132.
• The disposition was executed under a Rule 10b5-1 pre-arranged trading plan (Footnote 1), indicating the transaction was scheduled in advance.
• Following the sale, Dines鈥� beneficial ownership stands at 30,351,961 Class A shares (24,918,585 direct; 5,193,376 indirect via Ice Vulcan Holding Ltd.; 240,000 indirect via spouse), representing a minor reduction (~0.15%) of his total reported holdings.
• The price range for the trade was $12.67 鈥� $12.81; detailed breakdown is available upon request (Footnote 2).
• Control of the indirect shares remains with Dines through Ice Vulcan Holding Ltd., as detailed in Footnote 3.

This filing reflects a routine, plan-based sale that has a negligible impact on Dines鈥� overall stake and does not alter the company鈥檚 capital structure.

Alignment Healthcare (ALHC) 鈥� Amended Form 4 (Form 4/A)

CEO and Director John E. Kao corrected a prior Form 4 to reflect the accurate number of shares withheld for tax obligations triggered by the vesting of service-based restricted stock units (RSUs). On 08-Mar-2024, 35,801 common shares were automatically withheld at an implied price of $5.39 per share under Transaction Code 鈥淔鈥� (tax-withholding, non-discretionary). Following the adjustment, Kao鈥檚 direct beneficial ownership stands at 2,310,972 shares.

The filing explicitly states that no investment decision was made; the shares were removed solely to satisfy federal tax liabilities. The amendment rectifies an 鈥渁dministrative error鈥� in the original Form 4 filed on 12-Mar-2024.

• Nature of transaction: Non-open-market, tax-withholding event.
• Impact on insider鈥檚 stake: Less than 2% reduction in Kao鈥檚 holdings; he retains a substantial ownership position.
• Market significance: Typically viewed as neutral because it is mandatory and does not signal sentiment about ALHC鈥檚 prospects.

Sinclair, Inc. (SBGI) 鈥� Form 3 filing: Newly appointed Executive Vice President & Chief Financial Officer Narinder Sahai has reported initial beneficial ownership of 118,244 Class A common shares. The shares are issued as restricted stock that will vest 100% on July 7, 2028. No derivative securities were disclosed. The filing date is July 10, 2025 and the reportable event occurred on July 7, 2025. The ownership is held directly, indicating personal equity alignment with shareholders. No changes to outstanding share count, earnings, or major transactions are included in this brief compliance filing.